Details
| Stereochemistry | ACHIRAL |
| Molecular Formula | C6H12NO2P |
| Molecular Weight | 161.1387 |
| Optical Activity | NONE |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
CP(O)(=O)C1=CCNCC1
InChI
InChIKey=MFUKVPOVVKKLRQ-UHFFFAOYSA-N
InChI=1S/C6H12NO2P/c1-10(8,9)6-2-4-7-5-3-6/h2,7H,3-5H2,1H3,(H,8,9)
| Molecular Formula | C6H12NO2P |
| Molecular Weight | 161.1387 |
| Charge | 0 |
| Count |
|
| Stereochemistry | ACHIRAL |
| Additional Stereochemistry | No |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Optical Activity | NONE |
DescriptionSources: https://www.ncbi.nlm.nih.gov/pubmed/28460564
Sources: https://www.ncbi.nlm.nih.gov/pubmed/28460564
(1,2,5,6-tetrahydropyridine-4-yl)methylphosphinic acid (TPMPA) is a competitive antagonist of gamma-aminobutyric acid (GABA)C receptors.
Originator
Sources: https://www.ncbi.nlm.nih.gov/pubmed/8863850
Curator's Comment: 1996
Approval Year
Targets
| Primary Target | Pharmacology | Condition | Potency |
|---|---|---|---|
Target ID: CHEMBL2109242 Sources: https://www.ncbi.nlm.nih.gov/pubmed/8863850 |
Conditions
| Condition | Modality | Targets | Highest Phase | Product |
|---|---|---|---|---|
| Primary | Unknown Approved UseUnknown |
Sample Use Guides
In Vivo Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/28460564
TPMPA (100 μmol/rat) was administered intracerebroventricularly (ICV)
Route of Administration:
Other
In Vitro Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/26321868
Muscimol (100 μM) caused a transient increase of the [Ca(2+)]i in RPE cells regardless of whether Ca(2+) was added to the buffer. Muscimol-induced increases in the [Ca(2+)]i were inhibited by pretreatment with picrotoxin (300 μM) or TPMPA (500 μM).
| Substance Class |
Chemical
Created
by
admin
on
Edited
Mon Mar 31 23:26:18 GMT 2025
by
admin
on
Mon Mar 31 23:26:18 GMT 2025
|
| Record UNII |
TR7I0800L2
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Preferred Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English |
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
TPMPA
Created by
admin on Mon Mar 31 23:26:18 GMT 2025 , Edited by admin on Mon Mar 31 23:26:18 GMT 2025
|
PRIMARY | |||
|
182485-36-5
Created by
admin on Mon Mar 31 23:26:18 GMT 2025 , Edited by admin on Mon Mar 31 23:26:18 GMT 2025
|
PRIMARY | |||
|
m10992
Created by
admin on Mon Mar 31 23:26:18 GMT 2025 , Edited by admin on Mon Mar 31 23:26:18 GMT 2025
|
PRIMARY | Merck Index | ||
|
DTXSID801017153
Created by
admin on Mon Mar 31 23:26:18 GMT 2025 , Edited by admin on Mon Mar 31 23:26:18 GMT 2025
|
PRIMARY | |||
|
TR7I0800L2
Created by
admin on Mon Mar 31 23:26:18 GMT 2025 , Edited by admin on Mon Mar 31 23:26:18 GMT 2025
|
PRIMARY | |||
|
5520
Created by
admin on Mon Mar 31 23:26:18 GMT 2025 , Edited by admin on Mon Mar 31 23:26:18 GMT 2025
|
PRIMARY |